Clinical Study
A Retrospective Study on Pathologic Features and Racial Disparities in Prostate Cancer
Table 1
Differences in percentages of diagnoses at the first biopsy between African American and Caucasian.
| | Diagnosis | African American (n) | Caucasian (n) | P value |
| | Benign (%) | 37.2 (372) | 48.4 (370) | <0.0001a | | Age (Year, mean ± SD) | (376) | (370) | <0.0001 | | Serum PSA (ng/mL, median) | 5.7 (170) | 5.5 (146) | >0.05 | | PIN (%) | 9.1 (92) | 9.9 (76) | >0.05 | | Age (Year, mean ± SD) | (92) | (76) | >0.05 | | Serum PSA (ng/mL, median) | 6.7 (73) | 5.5 (39) | >0.05 | | ASAP (%) | 3.3 (33) | 2.9 (22) | >0.05 | | Age (Year, mean ± SD) | (33) | (22) | >0.05 | | Serum PSA (ng/mL, median) | 5.1 (21) | 5.8 (13) | >0.05 | | Prostate cancer (%) | 50.3 (509) | 38.3 (293) | <0.0001b | | Age (Year, mean ± SD) | (509) | (291) | 0.027 | | Serum PSA (ng/mL, median) | 11.6 (346) | 7 (162) | <0.0001 | | Gleason’s score (n/mean ± SD) | (502) | (289) | <0.0001 |
|
|
a: OR = 0.63, 95% CI: 0.52–0.76. b: OR = 1.63, 95% CI: 1.35–1.97.
|
